Acro Biomedical Co Ltd (ACBM)

Healthcare | Biotechnology
Income Statement (Quarterly) 2025-09-30 2025-06-30 2025-03-31 2023-06-30
Revenue 0 0 0 0
Cost of Revenue 0 0 0 0
Gross Profit 0 0 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 115,099 13,614 8,934 1,316,425
Operating Expenses 115,099 13,614 8,934 3,194,700
Operating Income -115,099 -13,614 -8,934 -3,194,700
Interest Expense 2,710 1,948 1,367 789
Income Before Tax -117,809 -15,562 -10,301 -3,195,489
Income Tax Expense 0 0 0 0
Net Income -117,809 -15,562 -10,301 -3,195,489
Per Share
EPS 0.00 0.00 0.00 -0.05
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2022-12-31 2021-12-31 2020-12-31 2019-09-30
Revenue 0 658,500 1,197,500 687,964 1,354,000
Cost of Revenue 0 518,000 938,000 528,560 1,218,600
Gross Profit 0 140,500 259,500 159,404 135,400
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 37,958 5,930,237 2,667,903 289,867 576,953
Operating Expenses 37,958 16,010,237 7,953,078 289,867 576,953
Operating Income -37,958 -15,869,737 -7,693,578 -130,463 -441,553
Interest Expense 4,339 1,706 4,250 5,082 2,265
Income Before Tax -42,297 -15,871,443 -7,697,828 -135,545 -443,818
Income Tax Expense 0 -15,869,737 0 -18,092 -73,071
Net Income -42,297 -15,871,443 -7,697,828 -117,453 -370,747
Per Share
EPS 0.00 -0.26 -0.14 0.00 -0.01
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2022-12-31 2021-12-31 2020-12-31
Assets
Cash and Cash Equivalents 476 5,852 95,248 18,123
Short Term Investments 0 0 0 0
Net Receivables 0 638,500 598,000 0
Inventory 0 12,000 0 938,000
Total Current Assets 5,076 657,537 706,415 973,353
Property Plant Equipment 26,898 25,719 50,432 24,700
Goodwill and Intangibles 0 0 0 0
Total Assets 31,974 687,486 761,077 998,053
Liabilities
Account Payables 0 76,571 26,197 24,734
Short Term Debt 26,898 25,719 24,713 24,500
Total Current Liabilities 326,946 201,116 91,651 312,185
Long Term Debt 0 0 25,719 0
Total Liabilities 326,946 201,116 117,370 312,185
Shareholders Equity
Retained Earnings -32,657,795 -23,807,925 -7,936,482 -238,654
Total Shareholders Equity -294,972 486,370 643,707 685,868
Balance Sheet (Annual) 2024-12-31 2022-12-31 2021-12-31 2020-12-31 2019-09-30
Assets
Cash and Cash Equivalents 476 5,852 95,248 18,123 1,472
Short Term Investments 0 0 0 0 0
Net Receivables 0 638,500 598,000 0 0
Inventory 0 12,000 0 938,000 1,060,000
Total Current Assets 5,076 657,537 706,415 973,353 1,069,464
Property Plant Equipment 26,898 25,719 50,432 24,700 0
Goodwill and Intangibles 0 0 0 0 0
Total Assets 31,974 687,486 761,077 998,053 1,069,464
Liabilities
Account Payables 0 76,571 26,197 24,734 18,024
Short Term Debt 26,898 25,719 24,713 24,500 0
Total Current Liabilities 326,946 201,116 91,651 312,185 195,792
Long Term Debt 0 0 25,719 0 0
Total Liabilities 326,946 201,116 117,370 312,185 195,792
Shareholders Equity
Retained Earnings -32,657,795 -23,807,925 -7,936,482 -238,654 -45,328
Total Shareholders Equity -294,972 486,370 643,707 685,868 873,672
Cash Flow Statement (Quarterly) 2024-12-31 2022-12-31 2021-12-31 2020-12-31
Operating Activities
Net Income -42,297 -15,871,443 -7,697,828 -117,453
Depreciation & Amortization 0 0 0 0
Stock Based Compensation 0 15,712,400 7,651,417 0
Change in Working Capital 0 9,856 341,296 -89,004
Operating Cash Flow -36,692 -147,481 299,335 -199,460
Investing Activities
Capital Expenditure 0 0 0 0
Investments 0 0 0 0
Investing Cash Flow 0 0 0 0
Financing Activities
Debt Repayment 0 -58,085 0 0
Common Stock Issued/Repurchased 0 0 0 0
Dividends Paid 0 0 0 0
Financing Cash Flow 36,792 58,085 -222,210 216,672
Summary
Free Cash Flow -36,692 -147,481 299,335 -199,460
Net Change in Cash 100 -89,396 77,125 17,212
Cash Flow Statement (Annual) 2024-12-31 2022-12-31 2021-12-31 2020-12-31 2019-09-30
Operating Activities
Net Income -42,297 -15,871,443 -7,697,828 -117,453 -370,747
Depreciation & Amortization 0 0 0 0 0
Stock Based Compensation 0 15,712,400 7,651,417 0 300,089
Change in Working Capital 0 9,856 341,296 -89,004 221,156
Operating Cash Flow -36,692 -147,481 299,335 -199,460 79,692
Investing Activities
Capital Expenditure 0 0 0 0 0
Investments 0 0 0 0 0
Investing Cash Flow 0 0 0 0 0
Financing Activities
Debt Repayment 0 -58,085 0 0 -186,337
Common Stock Issued/Repurchased 0 0 0 0 0
Dividends Paid 0 0 0 0 0
Financing Cash Flow 36,792 58,085 -222,210 216,672 -79,368
Summary
Free Cash Flow -36,692 -147,481 299,335 -199,460 79,692
Net Change in Cash 100 -89,396 77,125 17,212 324